Bringing Maximum Value to the KOL, Company and Industry

MSL
Co-Located
with ExLs

9th

Best Practices

September 26-27, 2011 | Hilton San Diego Resort & Spa | San Diego, CA

14th Investigator-Initiated Trials Conference

For maximum learning and networking opportunities!

Distinguished Speaking Faculty Joins us From:

ALLERGAN AMGEN AuXILIuM CAMPBELL ALLIANCE CELGENE CORPORATION FOLEY & LARDNER GENZYME MEDTRONIC MILLENNIuM PFIZER SHIRE TAKEDA TRINET PHARMA

Featured Sessions Include:

REACTIVE VS. PROACTIVE
How Can MSLs Manage Thought Leader Interactions in a Regulatory Environment that Favors a Reactive Model?
Krystene Woodard, Associate Director, ADHD MSL Team, SHIRE

MSL AND MEDICAL AFFAIRS COLLABORATION

Building and Maintaining Communication with Field-Based and Office-Based Teams to Strengthen Medical Strategy
Mohamed Yassine, Director and Therapeutic Lead, RMLs, AMGEN

PRE-CONFERENCE WORKSHOP: BUILDING AN MSL GROUP

Elizabeth Faust, PhD, VP, Medical Affairs and Head of Oncology Regional Medical Liaisons, CELGENE CORPORATION Susan Coughlin, PhD, Senior Director and National Lead, Solid-Tumor RMLs, CELGENE CORPORATION

Off-Label Information Interactive Roundtable Dissemination

Plus!

MSL Training Programs

MSL Team Prioritizing Cohesiveness MSL Activities

Career Development

Emerging KOLs

Discussions:

Sponsored by:

Register Now

866-207-6528 | www.exlpharma.com/9thmsl

Who Should Attend?

Dear Colleague,
Medical Science Liaisons (MSLs) are essential to the long term sustainability and success of pharmaceutical, biotech and medical device companies. Through the provision of sound scientific education, speaker development, insights on access/reimbursement, and research support, the importance of these knowledgeable and skilled individuals cannot be overestimated. As competition mounts, pipelines dry, and the regulatory environment becomes increasingly restrictive, MSLs must be armed with the tools and techniques for bringing maximum value to key opinion leaders, internal stakeholders, and corporate decision makers. Further, MSL managers and directors must be able to compliantly measure the effectiveness of their teams both in the field and in communicating across internal departments. ExL Pharmas 9th MSL Best Practices conference has a long history of offering targeted and highly practical content, in an engaging and interactive format. This event is a leader in the provision the latest information for enhancing the impact of MSLs, while offering ample networking opportunities. As the role of the MSL continues to evolve, this conference adapts to meet the increasing information needs of such a high level audience. We are excited to bring the most cutting edge concepts and techniques to our latest and greatest MSL program to date! We look forward to greeting you in September! Sincerely,
Professionals from Pharmaceutical, Biotechnology and Medical Device companies with responsibilities in the following areas: Departments/Titles Medical Science Liaisons (MSLS, MLs) Medical Advisors Scientific Advisors Medical Managers Medical Scientists Medical Affairs Scientific Affairs Regional Medical Education Officers Medical Communications Clinical Trial Liaisons Clinical Research Medical Education Clinical/Outcomes Liaisons Clinical Investigators KOL Development Business Intelligence Regulatory Affairs Marketing

Matt Millman Team Leader, Production ExL Pharma

Excellent seminarwill attend in the future

MSL, Millennium

This conference is also of interest to:

Software and Technology Companies Staffing Agencies/Recruiters Law Firms Consultants

Hilton San Diego Resort and Spa

1775 E. Mission Bay Drive, San Diego, CA 92109
The Hilton San Diego Resort & Spa is just six miles from the San Diego International Airport, and right on San Diegos famous Mission Bay. This resort and spa is conveniently located one mile from San Diego SeaWorld and offers 5-star service. A romantic paradise of palms and perfect sandy bayfronts, this bayside retreat is complete with our all-new $5 million dollar crown jewel, Spa Brezza, state-of-the-art fitness center, beautifully refreshed guestrooms, plus Concerts on the Bay. ROOM RESERVATIONS: If you require overnight accommodations, please contact the hotel and state that you are with ExL Pharmas MSL conference by Monday, September 5, 2011. We encourage conference participants to make reservations with our designated venue to take advantage of ExL Pharmas discounted room rate.

To Register Call 866-207-6528 or visit www.exlpharma.com/9thmsl

PRE-CONFERENCE WORKSHOP
DAY ONE Monday, September 26th
8:00 9:00 Registration and Continental Breakfast for Workshop Participants PRE-CONFERENCE WORKSHOP ESTABLISHING A NEW MSL TEAM Defining and Developing a Successful MSL Team Gaining cross-functional alignment on roles and responsibilities Determining size and structure Hiring, training, and deploying a new team Setting up a career ladder Elizabeth Faust, PhD, VP, Medical Affairs and Head of Oncology Regional Medical Liaisons, CELGENE CORPORATION Susan Coughlin, PhD, Senior Director and National Lead, Solid-Tumor RMLs, CELGENE CORPORATION Lunch For Workshop Attendees

I was really impressed with virtually everything about this event. The topics were right on target, the speakers were great, having lots of time for questions and interactive discussions was perfect.
Medical Scientific Manager, Allergan

Exceeded my expectations
- MSL, Tercica

12:00

MAIN CONFERENCE BEGINS DAY ONE

1:00 CHAIRPERSONS WELCOME AND OPENING REMARKS Elizabeth Faust, PhD, VP, Medical Affairs and Head of Oncology Regional Medical Liaisons, CELGENE CORPORATION MSL AND MEDICAL AFFAIRS COLLABORATION Building and Maintaining Communication with Field-Based and Office-Based Teams to Strengthen Medical Strategy Bringing thought leader insights to internal partners for coordinated KOL engagement Setting medical objectives that are aligned to corporate goals, mission and vision Utilizing information from medical teams to support MSL operations Establishing formal internal communication processes to promote clear, consistent and timely exchange of information Mohamed Yassine, Director and Therapeutic Lead, RMLs, AMGEN REACTIVE VS. PROACTIVE How Can MSLs Manage Thought Leader Interactions in a Regulatory Environment that Favors a Reactive Model? Are more teams solely contacting physicians in response to questions instead of setting up appointments? Is this more prevalent among new MSL teams? What tactics are MSLs using to maintain relationships and initiate contact with KOLs? Where is the industry headed and what can be done to change the perception that MSLs are an extension of sales? Krystene Woodard, Associate Director, ADHD MSL Team, SHIRE Networking and Refreshment Break 3:15 1:15 ADDING VALUE TO THE MSL ROLE Utilizing MSL Skill Sets and Expertise to Support Other Groups Within the Organization What is the traditional view of the MSL role What are ways to add value to, and increase visibility of, the work MSLs already do What are other activities MSLs can do to bring value to departments within the organization How are these activities prioritized and communicated internally What are the benefits and obstacles to increasing collaboration with internal departments Eric Churchill, PhD, MSL, MILLENNIUM PHARMACEUTICALS BEYOND METRICS Demonstrating Value Using Measures that Capture the Importance of MSLs to Corporate Business Objectives Determining the value MSLs bring to internal and external customers Going beyond reach and frequency to compliantly assess MSL performance Selecting quantitative and qualitative metrics that are fair and meaningful to both MSLs and their leadership Stephen Liu, PharmD, Regional Associate Director, TAKEDA PHARMACEUTICALS

4:00

2:00

Very well run and designed

National Clinical Science Manager, Abbott

2:45

To Register Call 866-207-6528 or visit www.exlpharma.com/9thmsl

MAIN CONFERENCE CONTINuES

DAY ONE Monday, September 26th
4:45 COCKTAIL RECEPTION & ROUNDTABLE SESSIONS WITH ATTENDEES FROM 14TH INVESTIGATOR-INITIATED TRIALS CONFERENCE Off-Label Information Dissemination: How can MSLs ensure compliant offlabel information sharing in the field?

1 4
6:00

2 5

MSL Training Programs: What components should be included in MSL training initiatives to enhance MSL knowledge and develop interpersonal skills? Career Development: Given the MSL skill set, what professional opportunities are complimentary within medical affairs, pharma, and other industries?

3 6

MSL Team Cohesiveness: How can managers best promote a positive, motivated group?

Prioritizing MSL Activities: What is the ideal allocation of MSL time and resources?

Emerging KOLs: What are best practices for building relationships with rising stars?

Close Of Day One/Close Of Cocktail Reception

MAIN CONFERENCE
8:00 9:00

DAY TWO Tuesday, September 27th

Panelists: Stacey Benefiel, Senior MSL Manager, Coronary and Peripheral, MEDTRONIC David Cram, PharmD, Vice President, Medical Affairs RSS Team, ALLERGAN Doug Wolf, Senior Director Team Leader Oncology RMRS, PFIZER 10:45 11:15 Networking and Refreshment Break KOL DEVELOPMENT Optimizing Thought Leader Engagement for Lasting Relationships throughout the Product Lifecycle Enhancing internal communication across departments for a coordinated outreach strategy Discussing best practices for identifying and working with rising stars Identifying compliance considerations when communicating with thought leaders CAMPBELL ALLIANCE INTERNAL STAKEHOLDER COLLABORATION Compliantly Communicating with Commercial Teams Maintaining compliance while sharing information with sales, marketing, managed care, and other internal partners Establishing and maintaining the firewall between commercial and medical teams Handling off-label information requests and information dissemination Michael R. Ujhelyi, PharmD, FCCP, Director, Medical Affairs and Safety, MEDTRONIC

Continental Breakfast for Conference Participants CHAIRPERSONS RECAP OF DAY ONE AND MODERATORS KEY POINTS FROM ROUNDTABLE DISCUSSIONS Elizabeth Faust, PhD, VP, Medical Affairs and Head of Oncology Regional Medical Liaisons, CELGENE CORPORATION LIFECYCLE MANAGEMENT Allocating Time and Resources to Different Functions based on the Products Stage in its Lifecycle Pre-Launch Phase: Successful strategies for KOL identification, enhancing disease state awareness and providing clinical support Launch Phase: Compliantly and effectively lending support to advisory boards, speaker training, managed care and possibly sales training Post-Launch Phase: Facilitating risk management, InvestigatorInitiated studies, and Phase IV studies through sustained scientific exchange with thought leaders Cindy Sellers OBrien, RN, BSN, MBA, Director, Medical Science Liaison Team - Solid Organ Transplant, GENZYME TRANSPLANT AND ONCOLOGY PANEL DISCUSSION: FUTURE TRENDS Looking at the Medical Science Liaison Position in 2015 How will the position evolve? How will regulations change? Will the numbers go up or down Moderator: Bryan Vaughan, Managing Member, TRINET PHARMA

9:15

12:00

10:00

To Register Call 866-207-6528 or visit www.exlpharma.com/9thmsl

MAIN CONFERENCE CONTINuES

DAY TWO Tuesday, September 27th
12:45 1:45 Luncheon for Conference Participants REMS: WHY IT IS IMPORTANT TO THE MSL ROLE Exploring the evolution and prevalence of REMS across the industry Discussing how MSLs can best support a REMS in collaboration with cross-functional departments Considering future trends and associated roles and responsibilities of MSLs in minimizing risk and supporting drug safety Gail Rosen Spahn, PharmD, Senior Director, Medical Affairs, AUXILIUM PHARMACEUTICALS Chairpersons Closing Remarks/Conference Concludes 2:30 LEGAL AND COMPLIANCE OVERVIEW Outlining Selected State, Federal and Industry Guidelines for Compliant Scientific Information Exchange Discussing the Sunshine Act provisions and their impact on MSL activities Reviewing state-mandated restrictions on industry-KOL interactions and the likelihood of other states following suit Highlighting industry and stakeholder initiated transparency Developing and enforcing SOPs to minimize risk and protect your company Judith Waltz, Partner, FOLEY & LARDNER LLP

3:30

Sponsorship and Exhibiting Opportunities

Do you want to spread the word about your organizations solutions and services to potential clients who will be attending this event? Take advantage of the opportunity to exhibit, present an educational session, host a networking event, or distribute promotional items to attendees. ExL Pharma will work closely with you to customize a package that will suit all of your needs. To learn more about these opportunities, please contact: Steve Decker, Business Development Manager 212-400-6234 | sdecker@exlpharma.com

Media Partners
Five Ways to Register Mail: ExL Events, Inc. 555 8th Ave, Ste 310 New York, NY 10018 212-400-6233 888-221-6750 register@exlpharma.com www.exlpharma.com/9thmsl
Group Discount Program: Save 25% per person when Registering Four For every three simultaneous registrations from your company, you will receive a fourth complimentary registration to the program (must register 4 at one time). This is a savings of 25% per person. Save 15% per person when Registering Three Can only send three? You can still save 15% off of every registration. To find out more on how you can take advantage of these group discounts, please call 866-207-6528. Important! Discounts may not be combined. Discount applies only to standard rate. Make checks payable to ExL Events, Inc. and write code P1130 on your check. You may also use Visa, MasterCard, Discover or American Express. Payments must be received in full prior to the commencement of the conference. Cancellations: If you need to cancel your registration for an upcoming ExL conference, please note the following policies derived from the Start Date of the event: Four weeks or more: A full refund (minus a $95 processing fee), or a voucher to another ExL event valid for two years from the voucher issue date. Four weeks or Less: A voucher to another ExL event valid for two years from the voucher issue date. To receive a refund or voucher, please fax your request to 888-221-6750. Please Note: Conference registrations may be transferred to other colleagues in the event you are unable to attend. There will be an administrative charge of $300 to substitute, exchange and/or replace attendance badges with a colleague occurring within five business days of any ExL conference. Please notify ExL Pharma, info@exlpharma.com, prior to the event with the name and contact information of the replacement attendee.

Phone: Fax: Email: Online:

EARLY BIRD PRICING Register by Friday, August 12, 2011 to Take Advantage of Early-Bird Pricing: Conference + Workshop Conference Only $1995 $1695

STANDARD PRICING Register After Friday, August 12, 2011: Conference + Workshop Conference Only ONSITE PRICING Conference + Workshop Conference Only $2195 $1895

*In the event of a cancellation or postponement ExL Events, Inc. will not be liable and/or responsible for any individual or group expenses related to said conference Please Note: Speakers and agenda are subject to change without notice. In the event of a speaker cancellation, every effort to find a suitable replacement will be made. *The opinions of this faculty do not necessarily reflect those of the companies they represent or ExL Events, Inc.*

$2295 $1995

To Register Call 866-207-6528 or visit www.exlpharma.com/9thmsl

To Register:
ExL Events, Inc. 555 8th Avenue, Suite 310 New York, NY 10018 866-207-6528 888-221-6750

METHOD OF PAYMENT: CARD TYPE:

q Check

q Credit Card Make checks payable to ExL Events, Inc. q Visa

Exp. Date:

q MasterCard

q Discover

q Amex

Card Number: Name on Card: Signature:

www.exlpharma.com/9thmsl
q Yes! Register me for the Conference Only

q Yes! Register Me for the Conference and Workshop

Please contact me: q Im interested in marketing opportunities at this event q I wish to receive email updates on Exl Pharmas upcoming events Name: Title: Company: Dept.: Address: City: Email: Telephone: Fax: State: Zip:

555 8th Avenue, Suite 310 New York, NY 10018

PLEASE MENTION PRIORITY CODE: P1130

Bringing Maximum Value to the KOL, Company and Industry

MSL
Co-Located
with ExLs

9th

Best Practices

September 26-27, 2011 | Hilton San Diego Resort & Spa | San Diego, CA

14th Investigator-Initiated Trials Conference

For maximum learning and networking opportunities!

Sponsored by:

Register Now

866-207-6528 | www.exlpharma.com/9thmsl